If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
102.80    0.40 (0.39%)
Bid:
102.80
Ask:
103.40
Spread: 0.60 (0.584%)
Market Cap: £124.90m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Holding(s) in Company

3 Jun 2013 16:42

RNS Number : 1820G
Impax Asset Management Group plc
03 June 2013
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Impax Asset Management Group plc (IPX:LSE)

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Sanne Trust Company Limited as trustee of the Impax Group plc Employee Benefit Trust 2012

4. Full name of shareholder(s)  (if different from 3.):iv

Shares held by Greenwood Nominees Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

31 May 2013

6. Date on which issuer notified:

3 June 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

13%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0004905260

16,594,043

16,594,043

15,584,143

15,584,143

12.20

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

15,584,143

12.20

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

The Impax Asset Management Group plc Employee Benefit Trust 2012 (the "Trust") has released shares to beneficiaries of the Trust and purchased shares resulting in the Trust holdings dropping through the 13% level.

14. Contact name:

Colum Spillane

15. Contact telephone number:

01534 750598

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASKDELFDEFF
Date   Source Headline
7th Oct 20207:00 amRNSAUM update
22nd Sep 20204:24 pmRNSHolding(s) in Company
18th Sep 202012:07 pmRNSSecond Price Monitoring Extn
18th Sep 202012:02 pmRNSPrice Monitoring Extension
20th Aug 20204:40 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 202012:07 pmRNSSecond Price Monitoring Extn
18th Aug 202012:02 pmRNSPrice Monitoring Extension
11th Aug 202012:07 pmRNSSecond Price Monitoring Extn
11th Aug 202012:02 pmRNSPrice Monitoring Extension
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSHolding(s) in Company
13th Jul 202012:30 pmRNSDirector/PDMR Shareholding
10th Jul 20205:52 pmRNSHolding(s) in Company
7th Jul 20207:00 amRNSQ3 AUM update
6th Jul 202012:07 pmRNSSecond Price Monitoring Extn
6th Jul 202012:02 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSInterim results to 31 March 2020
29th May 20204:40 pmRNSSecond Price Monitoring Extn
29th May 20204:35 pmRNSPrice Monitoring Extension
15th May 202012:02 pmRNSPrice Monitoring Extension
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20205:00 pmRNSNotice of Results
9th Apr 202012:02 pmRNSPrice Monitoring Extension
8th Apr 20204:40 pmRNSSecond Price Monitoring Extn
8th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSQ2 AUM update
6th Apr 202012:07 pmRNSSecond Price Monitoring Extn
6th Apr 202012:02 pmRNSPrice Monitoring Extension
24th Mar 202012:07 pmRNSSecond Price Monitoring Extn
24th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20203:56 pmRNSResult of AGM
19th Mar 20207:00 amRNSAGM Statement
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 202012:07 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Feb 20204:22 pmRNSHolding(s) in Company
9th Jan 20203:10 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSQ1 AUM Update
20th Dec 20194:40 pmRNSSecond Price Monitoring Extn
20th Dec 20194:35 pmRNSPrice Monitoring Extension
18th Dec 20195:14 pmRNSDirector/PDMR Shareholding
16th Dec 20194:36 pmRNSNotice of AGM
4th Dec 20195:58 pmRNSAnnual Financial Report
4th Dec 20197:00 amRNSFinal Results
27th Nov 20197:00 amRNSNotice of Results
8th Oct 20197:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.